Insider Shareholders with Direct Ownership of Evelo Biosciences, Inc. (EVLO)
This section provides a comprehensive overview of the insiders with direct ownership of Evelo Biosciences, Inc. (EVLO). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Evelo Biosciences, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Lord Ara Darzi
Director |
342,465 | 0 | 342,465 $0 | 1 |
May 27, 2022
Added 50.0%
|
David R Epstein
Director |
83,932 | 0 | 93,932 $0 | 13 |
Jun 30, 2022
Added 2.97%
|
Mark Bodmer
CSO, President of R&D |
158,250 | 103,730 | 25,732 $0 | 9 |
Nov 08, 2023
Reduced 10.95%
|
Marella Thorell
Chief Financial Officer |
155,500 | 46,345 | 22,259 $0 | 8 |
Nov 08, 2023
Reduced 7.52%
|
Simba Gill
President & CEO |
40,780 | 6,047 | 17,758 $0 | 8 |
Nov 08, 2023
Reduced 0.96%
|
Duncan Mc Hale
Chief Medical Officer |
189,746 | 80,121 | 16,984 $0 | 9 |
Nov 08, 2023
Reduced 15.45%
|
Mark D. Plinio
Chief Commercial Officer |
3,750 | 0 | 3,750 $0 | 3 |
Jan 31, 2023
Added 25.0%
|
Stephen J Carriere
Principal Accounting Officer |
354 | 151 | 203 $0 | 2 |
Jan 23, 2023
Reduced 42.66%
|
Xiaoli Jacqueline Liu
Principal Accounting Officer |
0 | 3,000 | 0 $0 | 1 |
Dec 01, 2020
Reduced 100.0%
|